On acceptable values of disregard limits for impurities and signal-to-noise ratio when checking chromatographic system sensitivity
Abstract
The article provides answers to urgent questions relating to the acceptable values of disregard limits for impurities and signal-to-noise ratio ( S / N ) when checking the sensitivity of the chromatographic system. It gives recommendations on the «typical» and maximum acceptable values of disregard limits for impurities. The article also demonstrates that the requirement of S / N ≥ 10 can be unnecessarily rigid in some cases: there could be found convincing arguments justifying a smaller S / N value for the sensitivity solution, for example, in cases when an identified impurity is determined by a specific procedure and the impurity peak appears before the peak of the main substance.
About the Author
N. A. Epshtein
Autonomous corporation «STADA PharmDevelopment», JSC «NIZHPHARM»
Russian Federation
Russian Federation
References
1. State Pharmacopoeia of the Russian Federation. 13th ed. V. I. Moscow; 2015. Available from: http://femb.ru/feml (in Russian).
2. European Pharmacopoeia. 9th ed. Strasbourg; 2017.
3. Frequently Asked Questions about the EDQM and Helpdesk List. Topics: 04. European Pharmacopoeia & International Harmonisation. 01. General Chapters and Monographs. 06. Impurities Chromatography. 05. How to determine the total impurities? Which peaks can be disregarded? Available from: https://goo.gl/9AfcqH.
4. Technical Guide for the Elaboration of Monographs. 7th ed. EDQM. European Pharmacopoeia; 2015. Available from: https://goo.gl/EVp8kf.
5. ICH Harmonised Tripartite Guideline. Q3A(R2). Impurities in New Drug Substances. ICH; 2006.
6. ICH Harmonised Tripartite Guideline. Q3B(R2). Impurities in New Drug Products. ICH; 2006.
7. Meyer C, Seiler P, Bies C, Cianciulli C, Watzig H, Meyer VR. Minimum required signal-to-noise ratio for optimal precision in HPLC and CE. Electrophoresis 2012; 33(11): 1509–16.
8. Snyder LR, Kirkland JJ, Glajch JL. Practical HPLC Method Development. 2nd ed. New York: J. Wiley; 1997.
9. United States Pharmacopoeia. National Formulary USP 39 — NF 34. Rockville; 2016.
10. Kuss H-J, Kromidas S, eds. Quantification in LC and GC. A practical guide to good chromatographic data. Wheinheim: WILEY-VCH Verlag GmbH& Co, KGaA; 2009.
11. ICH Harmonised Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology Q2(R1). ICH; 2005.
12. Epshtein NA. Validation of HPLC Techniques for Pharmaceutical Analysis. Pharmaceutical Chemistry Journal 2004; 38(4): 40–56 (in Russian).
13. Beregovykh VV, ed. Validation of analytical procedures for drug manufacturers. Guiding principles for drug manufacturers. Moscow: Litterra; 2008 (in Russian).
14. HPLC Simulator 6.0. Available from: http://hplc-simulator.software.informer.com/6.0/.
15. Meyer VR. Practical High-Performance Liquid Chromatography. 5th ed. Chichester: John Wiley and Sons; 2010.
16. Pauls RE, McCoy RW, Ziegel ER, Wolf T, Fritz GT, Marmion DM. Results of a Cooperative Study Comparing the Precision of Peak Height and Area Measurements in Liquid Chromatography. Part II. J Chromatogr Sci 1986; 24(7): 273–7.
17. Commentary USP 39 — NF 34. US Pharmacopeial Convention. November 2, 2015. Available from: https://goo.gl/wPovtY.
18. Chambers D, Kelly G, Limentani G, Lister A, Lung KR, Warner E. Analytical method equivalency: An acceptable analytical practice. Pharmaceut Technol. 2005; 29: 64–80.
Review
For citations:
Epshtein N.A. On acceptable values of disregard limits for impurities and signal-to-noise ratio when checking chromatographic system sensitivity. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2017;7(2):85-91. (In Russ.)
Views:
1828
Email this article 